Single-patient access to tradipitant for gastroparesis with nausea
Treatments studied
Part of Digestive system clinical trials.
This is a special single-patient program for a person with gastroparesis who has moderate to severe nausea. It provides access to an investigational drug called tradipitant, which may help relieve nausea, when no other clinical trials are available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gastroparesis and have shown delayed stomach emptying on a test.
- You have moderate to severe nausea.
- You are not eligible for or do not have access to other clinical trials of the study drug.
- You do not have another condition or treatment that could explain your symptoms.
- You have not used any investigational medication (other than the study drug) in the past 60 days.
- You have not had certain stomach surgeries (like gastric bypass or a stomach pacemaker) in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to program an implanted device (Enterra®) to better treat severe nausea and vomiting caused by gastroparesis. If you have frequent nausea and vomiting despite other treatments, this study might help find a better setting for your device.
This study is testing the safety of an investigational drug called tradipitant in people with stomach paralysis (gastroparesis) caused by unknown reasons or diabetes. It looks at how well the drug is tolerated over time.
This study follows people with drug-refractory gastroparesis (stomach paralysis symptoms that don’t improve with usual medicines) to better understand how symptoms and nutrition change over time. Your information may help researchers understand patterns that could improve care.
This trial tests a procedure called G-POEM that may help with severe gastroparesis, where the stomach is slow to empty. It aims to improve blood sugar control and stomach symptoms for people with diabetes.
This study looks at whether abnormal function of the pyloric “stomach outlet” muscle is linked to gastroparesis symptoms (slow stomach emptying). It may help researchers better understand what causes symptoms and guide future treatments.
This trial compares two treatments for gastroparesis: a procedure called G-POEM (which opens the stomach's outlet valve) and a feeding tube (PEG-J) that bypasses the stomach. It aims to see which is better at helping food move through the stomach.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.